Enzyme-Prodrug Strategies For Cancer Therapy-..
R$ 1.825,92
até
4x
de
R$ 456,48
sem juros
ou R$ 1.734,62
via Pix
Adicionar ao carrinho
Disponibilidade: 45 dias úteis
Estoque: 113 unidades
-
- 1x de R$ 1.825,92 sem juros
- 2x de R$ 912,96 sem juros
- 3x de R$ 608,64 sem juros
- 4x de R$ 456,48 sem juros
-
R$ 1.734,62
-
R$ 1.825,92
Antibody-directed enzyme prodrug therapy (ADEPT) directly addresses the major problem in cancer chemotherapy-its lack of selectivity. Antibody delivery combined with the amplification provided by the enzymatic activation of prodrugs enables selection to be made between tumour and normal tissue. ADEPT offers a novel field of opportunities in the therapy of systemic cancer and may be a major advance for the treatment of solid tumours. This book is the first to describe ADEPT in detail. Each chapter reviews an aspect of the immunology, enzymology, biochemistry, chemistry, and cancer chemotherapy which have been integrated into the ADEPT concept. An additional chapter describes the related approach of gene-directed enzyme prodrug therapy (GDEPT). This latter approach is still in its infancy but ADEPT has entered the clinic. The initial clinical studies with ADEPT are included and discussed in detail.
| ISBN | 9780306458958 |
| Autor(a) | Melton, Roger G. |
| Editora | Springer Publishing |
| Ano de edição | 1999 |
| Páginas | 257 |
| Acabamento | Capa Dura |
Produtos relacionados
-
Enzyme-Prodrug Strategies For Cancer Therapy-..R$ 1.825,92até 4x de R$ 456,48 sem jurosou R$ 1.734,62 via Pix -
Enzyme Based Approaches In Cancer Healthcare Management-..R$ 1.825,92R$ 1.460,74até 4x de R$ 365,18 sem jurosou R$ 1.387,70 via Pix20% Desconto -
Current Strategies In Cancer Gene Therapy-..R$ 1.327,92R$ 1.062,34até 4x de R$ 265,58 sem jurosou R$ 1.009,22 via Pix20% Desconto -
Current Strategies In Cancer Gene Therapy-..R$ 1.327,92R$ 1.062,34até 4x de R$ 265,58 sem jurosou R$ 1.009,22 via Pix20% Desconto
-
Categorias
Pague com
Selos
MYRE EDITORA, COMERCIALIZADORA, IMPORTADORA E DISTRIBUIDORA LTDA - CNPJ: 50.295.718/0001-20 © Todos os direitos reservados. 2026
